In Depth 8 Jul 2024
Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR
Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique.
Gene editing
- Latest Posts
In Depth 6 Jun 2024
CRISPR: A promising path to treating blindness
Rigorous research, which has been going on for more than a decade now, suggests that CRISPR could treat genetic diseases including blindness.
In Depth 5 Jun 2024
Evolving standards of care: new treatments for cervical cancer
New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients.
In Depth 23 May 2024
Is prime editing ready for prime time?
Prime editing, a more advanced version of CRISPR/Cas9 technology, has been greenlit by the FDA to begin the first-ever clinical trial for this technology.
Best in Biotech 21 May 2024
Eight companies spearheading Philadelphia’s biotech industry
Often called the Cellicon Valley due to its focus on cell and gene therapy, discover eight Philadelphia biotech companies to know about.
Best in Biotech 18 Apr 2024
5 RNA editing companies you should know about
Check out five RNA editing companies on a mission to find a safer alternative to traditional gene editing techniques.
ADVERTISEMENT
ADVERTISEMENT
In Depth 10 Apr 2024
Silencing genes to cure diseases: an in-depth look at siRNA
Delve into the promissing and dynamic sector of siRNA technology, with new drug approvals and advancements in delivery methods.
In Depth 4 Apr 2024
Seven diseases CRISPR technology could cure
Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool.
Podcast 1 Mar 2024
The final chapter in genomic medicines?
Explore the future of genomic medicine with Tome Biosciences’ programmable genomic integration technique, set to revolutionize gene editing.
Best in Biotech 22 Feb 2024
10 gene therapy companies you should know about
Explore 10 gene therapy companies operating within the biotech industry, as each one hopes to develop their own novel candidates.
In Depth 12 Feb 2024
RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?
Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time.
Best in Biotech 22 Jan 2024
Eight newly approved drugs that could become blockbusters in 2024
The much-awaited Drugs to Watch list by Clarivate is out. Let’s do a deep dive into the therapies that made the cut in 2024.
ADVERTISEMENT
